Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Clin Pharmacol. 2016 Mar 28;56(9):1060–1075. doi: 10.1002/jcph.715

Table 1.

Classification of Quinolones

Generation Drugs Spectrum of Activity
Anaerobes/Atypicals
Gram Positive Gram Negative
First Nalidixic acida
Cinoxacin
Minimal Gram-positive Enterobacteriaceae None
Second Ciprofloxacinb,c
Levofloxacinb,d
Enoxacin
Fleroxacin
Ofloxacin
Lomefloxacin
Norfloxacin
Pefloxacin
Methicillin-susceptible Staphylcoccus aureus, Streptococcus pneumoniae, Other streptococci Enterobacteriaceae Pseudomonas aeruginosa Haemophilus spp., Neisseria spp., Moraxella catarrhalis Legionella pneumophila, Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum, Mycobacterium spp
Thirde Gatifloxacin
Grepafloxacin
Sparfloxacin
Temafloxacin
Methicillin-susceptible S. aureus, S. pneumoniae, Listeria monocytogenes, Other streptococci Enterobacteriaceae Haemophilus spp., Neisseria spp., Moraxella catarrhalis Legionella pneumophila Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum Mycobacterium spp
Fourth Moxifloxacinb,f
Trovafloxacin
Gemifloxacin
Methicillin-susceptible S. aureus, S. pneumoniae, Other streptococci Enterobacteriaceae Haemophilus spp., Neisseria spp., Moraxella catarrhalis Legionella pneumophila, Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum, Mycobacterium spp. Anaerobes
a

Only indicated for urinary tract infections due to low systemic exposure.

b

Most commonly prescribed.

c

Greatest activity against Pseudomonas aeruginosa.

d

Greatest activity against Streptococcus pneumoniae.

e

Not available in the United States or removed from the market.

f

Additional activity against anaerobes.